Advanced Nanotechnology for Biomedical Research: Diagnosis, Drug Delivery and Targeted Therapy
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: closed (30 March 2024) | Viewed by 1578
Special Issue Editor
Interests: radiation therapy; nanoparticles; MR-linac; proton therapy; cancer therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology has opened up new horizons in the field of biomedical research, spanning areas such as diagnosis, drug delivery, targeted therapy, and beyond. Nanomaterials, boasting multifaceted characteristics, emerge as prime candidates for biomedical applications. Their key attributes, including increased loading capacity, expanded surface area, the potential for inducing reactive oxygen species, and adaptability for surface functionalization, position them at the forefront of innovation.
Recent studies have demonstrated the high efficacy of nanomaterials in diverse biomedical applications, encompassing bioimaging, biosensing, gene delivery, drug delivery, photothermal therapy, hyperthermia, combination therapy, and concurrent diagnostics and therapy (theranostics). Consequently, this Special Issue aims to delve into the pivotal role of nanomaterials in advancing biomedical research.
This Special Issue of Nanomaterials, titled 'Advanced Nanotechnology for Biomedical Research', seeks to assemble original research and review articles that shed light on the synthesis, modification, design, properties, and applications of biomedical nanomaterials in various domains. We cordially invite scientists and engineers from diverse multidisciplinary backgrounds, each with their unique technological expertise, to contribute their work to this Special Issue.
Dr. Abdul K. Parchur
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- targeted therapy
- cancer nanotherapy
- nanocarriers
- diagnosis
- bioimaging
- biosensing
- biomedical nanomaterials
